Periodontitis, an inflammatory disorder driven by microbial dysbiosis, is featured as elevated reactive oxygen species (ROS) and dysregulated inflammation, leading to tissue destruction and alveolar bone resorption. A promising therapeutic approach involves antimicrobial actions with ROS neutralization. Addressing the clinical limitation of elemental iodine (I2) to topical use, we engineered a ROS-scavenging covalent cyclodextrin framework (CCF) embedding I2 to confer dual functionality for periodontitis treatment. Initially, potassium iodide cyclodextrin metal-organic framework (KI-CD-MOF) was synthesized, which was then cross-linked with oxalyl chloride to introduce a ROS-scavenging peroxalate ester bond. Simultaneously, the iodide ions in KI-CD-MOF were oxidized to I2, which was integrated throughout the framework. The resulting I2-CCF particles had a cubic morphology (300–500 nm) and an I2 content of 1.03±0.45 %, exhibiting an outstanding biosafety profile, strong bactericidal effectiveness, and significant ROS elimination capability. In vitro, I2-CCF downregulated the expression of pro-inflammatory factors TNF-α and IL-1β, while promoting the secretion of anti-inflammatory markers IL-10 and Arg-1. Crucially, in a rodent periodontitis model, I2-CCF effectively suppressed dental plaque accumulation, reduced periodontal inflammation, and limited alveolar bone resorption. This work establishes I2-CCF as a multipurpose nanotherapeutic that concurrently targets the infectious and oxidative components of periodontitis, offering a potent alternative to conventional treatments.
扫码关注我们
求助内容:
应助结果提醒方式:
